Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 45.95
-0.20 (-0.43%)
Jul 17, 2025, 5:35 PM CET
Pharmanutra Revenue
In the year 2024, Pharmanutra had annual revenue of 116.15M EUR with 15.33% growth. Pharmanutra had revenue of 32.20M in the quarter ending December 31, 2024, with 11.62% growth.
Revenue
116.15M
Revenue Growth
+15.33%
P/S Ratio
3.82
Revenue / Employee
984.31K
Employees
118
Market Cap
443.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 116.15M | 15.44M | 15.33% |
| Dec 31, 2023 | 100.71M | 17.64M | 21.24% |
| Dec 31, 2022 | 83.06M | 14.92M | 21.89% |
| Dec 31, 2021 | 68.14M | 11.38M | 20.04% |
| Dec 31, 2020 | 56.77M | 3.10M | 5.78% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.41B |
| DiaSorin | 1.21B |
| Amplifon | 2.42B |
| EL.En. | 577.19M |
| Philogen | 77.65M |
| Safilo Group | 993.22M |
| Garofalo Health Care | 470.20M |
| GPI S.p.A. | 509.93M |